254 related articles for article (PubMed ID: 20600514)
1. Glycoconjugate vaccines and immune interference: A review.
Dagan R; Poolman J; Siegrist CA
Vaccine; 2010 Aug; 28(34):5513-23. PubMed ID: 20600514
[TBL] [Abstract][Full Text] [Related]
2. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
[TBL] [Abstract][Full Text] [Related]
3. Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines.
Tontini M; Berti F; Romano MR; Proietti D; Zambonelli C; Bottomley MJ; De Gregorio E; Del Giudice G; Rappuoli R; Costantino P; ; Brogioni G; Balocchi C; Biancucci M; Malito E
Vaccine; 2013 Oct; 31(42):4827-33. PubMed ID: 23965218
[TBL] [Abstract][Full Text] [Related]
4. Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules.
Borrow R; Dagan R; Zepp F; Hallander H; Poolman J
Expert Rev Vaccines; 2011 Nov; 10(11):1621-31. PubMed ID: 22043960
[TBL] [Abstract][Full Text] [Related]
5. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
6. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
Pecetta S; Tontini M; Faenzi E; Cioncada R; Proietti D; Seubert A; Nuti S; Berti F; Romano MR
Vaccine; 2016 Apr; 34(20):2334-41. PubMed ID: 27015733
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
Bröker M; Berti F; Schneider J; Vojtek I
Vaccine; 2017 Jun; 35(25):3286-3294. PubMed ID: 28487056
[TBL] [Abstract][Full Text] [Related]
8. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
Chu C; Schneerson R; Robbins JB; Rastogi SC
Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
[TBL] [Abstract][Full Text] [Related]
9. Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates.
Bröker M
Hum Vaccin Immunother; 2016 Mar; 12(3):664-7. PubMed ID: 26327602
[TBL] [Abstract][Full Text] [Related]
10. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
11. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
[No Abstract] [Full Text] [Related]
12. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
Vella PP; Ellis RW
Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
[TBL] [Abstract][Full Text] [Related]
14. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.
Barington T; Skettrup M; Juul L; Heilmann C
Infect Immun; 1993 Feb; 61(2):432-8. PubMed ID: 7678586
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
[TBL] [Abstract][Full Text] [Related]
16. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA;
Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
[TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
20. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
